Indaptus Therapeutics Inc

Research Indaptus Therapeutics Inc (INDP) on Bullrun: market cap USD 346.52M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerINDP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 346.52M
• Financial periodFY2025
• Net income-USD 20.85M

Valuation Snapshot

latest market cap is USD 346.52M.

About Indaptus Therapeutics Inc

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors.

Frequently asked questions

What is Indaptus Therapeutics Inc's market cap?

Indaptus Therapeutics Inc's market capitalization is USD 346.52M.

What does Indaptus Therapeutics Inc do?

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.